Status:
COMPLETED
Changes of Oropharyngeal Flora
Lead Sponsor:
Region Skane
Collaborating Sponsors:
Probi AB
Conditions:
Pharyngeal Bacterial Colonization
Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hospitalised patients have in contrast to healthy people enteric pathogenic bacteria in their oropharynx Increased risk of pneumonia due to the pathogens in the oropharynx Probiotics can reduce such b...
Detailed Description
When patients are admitted to hospital some of them are already colonized in the oropharynx with pathogens that are normally found as commensal or possible pathogens in the gastrointestinal tract. Thi...
Eligibility Criteria
Inclusion
- Admitted to hospital
- Anticipated length of hospital stay 3 days or more
Exclusion
- Immune insufficiency
- Prior participation in the study
- Not being able to understand study information
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT02303301
Start Date
October 1 2014
End Date
July 1 2020
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lund University Hospital
Lund, Sweden, SE-22185